Skip to main content
Clinical Trials/NCT05246969
NCT05246969CompletedNot Applicable

Detecting Sepsis in Patients With Severe Subarachnoideal Hemorrhage

Goethe University1 site in 1 country58 target enrollmentStarted: June 1, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
58
Locations
1
Primary Endpoint
Sepsis SOFA positive

Study Overview

Brief Summary

The study aims to evaluate the suitability of the SOFA score implemented by the Sepsis 3 guideline to detect sepsis in patients suffering from subrarachnoid hemorrhage.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Critically ill patients suffering from moderate to severe subarachnoid hemorrhage (WFNS >2).

Exclusion Criteria

  • children under the age of 18 years Patients with minor subarachnoid hemorrhage < WFNS stage 2.

Outcomes

Primary Outcomes

Sepsis SOFA positive

Time Frame: up to 2 months

Sepsis correctly detected by SOFA score (Sepsis-related organ failure assessment score, 0-24 points)

Sepsis SOFA negative

Time Frame: up to 2 months

Sepsis not detected by SOFA score (Sepsis-related organ failure assessment score, 0-24 points)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Goethe University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Armin N. Flinspach

Principal Investigator

Goethe University

Study Sites (1)

Loading locations...

Similar Trials